TheScreener - Dishman Pharmaceuticals Chemicals (DISH) DISHMAN PHARMS. CHML. sees an upgrade to Positive due to a better fundamental star rating

Report

TheScreener

EUR 13.26 For Business Accounts Only

DISHMAN PHARMS.& CHML. sees an upgrade to Positive due to a better fundamental star rating

The general evaluation of DISHMAN PHARMS.& CHML. (IN), a company active in the Pharmaceuticals industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as defensive. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Positive. As of the analysis date June 23, 2017, the closing price was INR 301.20 and its potential was estimated at INR 371.76.

26/06/2017 6 EN

Underlying

Dishman Pharmaceuticals & Chemicals

Dishman Pharmaceuticals and Chemicals Ltd Formerly known as Dishman Pharmaceuticals & Chemicals LimitedDishman Carbogen Amcis Limited. Dishman Pharmaceuticals and Chemicals Limited, formerly Dishman Pharmaceuticals and Chemicals Limited, operates as an outsourcing partner for the pharmaceutical industry. The Company manufactures and supplies intermediates, fine chemicals and various products for pharmaceutical, cosmetic and related industries. The Company's segments include Contract Research & Contract Manufacturing (CRAMS), and Bulk Drugs, Intermediates, Quats, Specialty Chemicals and Traded Goods. The Company's CRAMS business segment caters to the requirements of multinational pharmaceutical companies across the world. The Company's product portfolio includes Active Pharmaceutical Ingredients (APIs), High Potent APIs, Intermediates, Phase transfer catalysts, Lanolin-related products, and Antiseptic and disinfectant formulations. Its business units include Generic API, Dishman Specialty Chemicals, and Dishman Care.

See profile

INE353G01020 India

Provider

TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.

See profile

Other Reports on these Companies

IDFC Securities

Dishman Carbogen Amcis' Q4FY18 results (Outperformer) - Below est; business momentum intact

Q4FY18 result highlights Net revenues were down 15%yoy (flat qoq) to Rs4.5bn, below our estimates of Rs5bn; Both CRAMS and MM segments were lower yoy. FY18 revenue of Rs16.96bn is marginally lower yoy. Adjusted for the change in the accounting treatment for unrealized forex gains, revenues were marginally higher qoq. Other operating income was negative Rs10.6mn vs Rs289mn (realised forex gains of Rs175mn) in Q3FY18 and Rs471mn in Q4FY18. Led by lower revenues, reported EBITDA stood lower at Rs1.2bn (26.8%) vs our est of Rs1.4bn (28% margins). EBITDA was flat qoq Depreciation came in lowe...

May 21, 2018 May 21, 2018 10 EN

IDFC Securities

Dishman Carbogen Amcis' Q4FY18 results (Outperformer) - Below est; business momentum intact

May 18, 2018 May 18, 2018 10 EN

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

AC ENERGY CORP (PH), a company active in the Alternative Electricity industry, now shows a lower overall rating. The independent financial analyst theScreener confirms the fundamental rating of 4 out of 4 stars. However, the market behaviour deterioration triggered a risk requalification, which can be thus described as moderately risky. theScreener believes that increased risk justifies the general evaluation downgrade to Neutral. As of the analysis date April 8, 2022, the closing price was PHP 8.54 and its expected value was estimated at PHP 8.53.

Free Trial

April 9, 2022 April 9, 2022 1 EN

With a more favourable environment, VUKILE PROPERTY improves to Positive

VUKILE PROPERTY (ZA), a company active in the Real Estate Holding & Development industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 4 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Positive. As of the analysis date April 5, 2022, the closing price was ZAR 13.72 and its potential was estimated at ZAR 15.16.

Free Trial

April 6, 2022 April 6, 2022 1 EN

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

The independent financial analyst theScreener just requalified the general evaluation of ROYAL BAFOKENG PLATINUM (ZA), active in the Platinum & Precious Metals industry. As regards its fundamental valuation, the title still shows 0 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date April 5, 2022, the closing price was ZAR 159.78 and its target price was estimated at ZAR 127.50.

Free Trial

April 6, 2022 April 6, 2022 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

DISHMAN PHARMS.& CHML. sees an upgrade to Positive due to a better fundamental star rating

Empowering Investors

Dishman Carbogen Amcis' Q4FY18 results (Outperformer) - Below est; business momentum intact

Dishman Carbogen Amcis' Q4FY18 results (Outperformer) - Below est; business momentum intact

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

With a more favourable environment, VUKILE PROPERTY improves to Positive

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe